ELIZABETH SMITH: Open Payments
NPI 1770299315 · VERSAILLES, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,464 in 69 payments from 17 companies in 2025. Trend: 2023 $215 · 2024 $1,657 · 2025 $1,464
Food & beverage: $1,464
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $296 |
| Novo Nordisk Inc | 9 | $226 |
| GlaxoSmithKline, LLC. | 10 | $176 |
| ABBVIE INC. | 14 | $169 |
| Endo USA, Inc. | 1 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $96 |
| Amgen Inc. | 5 | $77 |
| Lilly USA, LLC | 3 | $53 |
| Astellas Pharma US Inc | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
Products named: FARXIGA, Ozempic, TRELEGY ELLIPTA, XIAFLEX, QULIPTA, AIRSUPRA, Rybelsus, Kerendia.
Industry payments across KY — which companies pay providers there.
